Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:453-455
doi: 10.1161/CIRCULATIONAHA.107.188518
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2008;117:453-455.)
© 2008 American Heart Association, Inc.

Clinical Summaries


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Catheter Ablation for the Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillators: Short- and Long-Term Outcomes in a Prospective Single-Center Study
 
Multiple shocks resulting from repetitive episodes of ventricular tachycardia, known as electrical storm (ES), occur in 10% to 20% of patients with implantable cardioverter-defibrillators. This frightening clinical emergency also predicts an increased risk of subsequent cardiac death among survivors. This case series assesses the role of catheter ablation in controlling ES and the subsequent long-term incidence of recurrent ventricular tachycardia and cardiac mortality. Ninety-five patients with structural heart disease undergoing catheter ablation for drug-refractory ES were prospectively evaluated. Advanced strategies of mapping and ablation were used in most patients. After 1 to 3 procedures, ES was suppressed in all patients. Programmed electrical stimulation showed that all inducible clinical ventricular tachycardias were abolished in 89% of patients. At a median follow-up of 22 months, 92% of patients were free of ES; 8 patients had recurrent ES, 4 of whom died despite implantable cardioverter-defibrillator intervention. The total cardiac mortality rate was 12%, which compares favorably with the reported late mortality rates for patients who suffer ES. Acute results of catheter ablation predicted the absence of ES recurrence and correlated with reduced cardiac mortality. These observations support the early use of catheter ablation as adjunctive therapy for the treatment of ES. This experience lays the foundation for further studies to determine whether controlling ES with catheter ablation improves long-term survival. See p 462.


*    Pulmonary Vein Region Ablation in Experimental Vagal Atrial Fibrillation: Role of Pulmonary Veins Versus Autonomic Ganglia
 
Ablation procedures directed at the pulmonary vein (PV) region have had a very important impact on the management of atrial fibrillation (AF). PV-directed procedures initially targeted highly localized arrhythmogenic . . . [Full Text of this Article]


Related Articles:

Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women: Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study)
Kyoichi Mizuno, Noriaki Nakaya, Yasuo Ohashi, Naoko Tajima, Toshio Kushiro, Tamio Teramoto, Shinichiro Uchiyama, Haruo Nakamura for the MEGA Study Group
Circulation 2008 117: 494-502. [Abstract] [Full Text]

Catheter Ablation for the Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillators: Short- and Long-Term Outcomes in a Prospective Single-Center Study
Corrado Carbucicchio, Matteo Santamaria, Nicola Trevisi, Giuseppe Maccabelli, Francesco Giraldi, Gaetano Fassini, Stefania Riva, Massimo Moltrasio, Manuela Cireddu, Fabrizio Veglia, and Paolo Della Bella
Circulation 2008 117: 462-469. [Abstract] [Full Text]

Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia
Jalal K. Ghali, Inder S. Anand, William T. Abraham, Gregg C. Fonarow, Barry Greenberg, Henry Krum, Barry M. Massie, Scott M. Wasserman, Marie-Louise Trotman, Yan Sun, Beat Knusel, Paul Armstrong on behalf of the Study of Anemia in Heart Failure Trial (STAMINA-HeFT) Group
Circulation 2008 117: 526-535. [Abstract] [Full Text]

Vitamin D Deficiency and Risk of Cardiovascular Disease
Thomas J. Wang, Michael J. Pencina, Sarah L. Booth, Paul F. Jacques, Erik Ingelsson, Katherine Lanier, Emelia J. Benjamin, Ralph B. D’Agostino, Myles Wolf, and Ramachandran S. Vasan
Circulation 2008 117: 503-511. [Abstract] [Full Text]

Genetic Variation Within Adrenergic Pathways Determines In Vivo Effects of Presynaptic Stimulation in Humans
Maple M. Fung, Carie Nguyen, Parag Mehtani, Rany M. Salem, Brandon Perez, Brenda Thomas, Madhusudan Das, Nicholas J. Schork, Sushil K. Mahata, Michael G. Ziegler, and Daniel T. O’Connor
Circulation 2008 117: 517-525. [Abstract] [Full Text]

Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study
Deborah M. Friedman, Mimi Y. Kim, Joshua A. Copel, Claudine Davis, Colin K.L. Phoon, Julie S. Glickstein, Jill P. Buyon for the PRIDE Investigators
Circulation 2008 117: 485-493. [Abstract] [Full Text]

Apoptosis Signal-Regulating Kinase 1/p38 Signaling Pathway Negatively Regulates Physiological Hypertrophy
Masayuki Taniike, Osamu Yamaguchi, Ikuko Tsujimoto, Shungo Hikoso, Toshihiro Takeda, Atsuko Nakai, Shigemiki Omiya, Isamu Mizote, Yuko Nakano, Yoshiharu Higuchi, Yasushi Matsumura, Kazuhiko Nishida, Hidenori Ichijo, Masatsugu Hori, and Kinya Otsu
Circulation 2008 117: 545-552. [Abstract] [Full Text]

Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children: Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial
Jennifer S. Li, Eric Yow, Katherine Y. Berezny, Paula M. Bokesch, Matsato Takahashi, Thomas P. Graham, Jr, Stephen P. Sanders, Daniel Sidi, Damien Bonnet, Peter Ewert, Lisa K. Jennings, Alan D. Michelson for the PICOLO Investigators
Circulation 2008 117: 553-559. [Abstract] [Full Text]

Risk Associated With Preoperative Anemia in Cardiac Surgery: A Multicenter Cohort Study
Keyvan Karkouti, Duminda N. Wijeysundera, W. Scott Beattie for the Reducing Bleeding in Cardiac Surgery (RBC) Investigators
Circulation 2008 117: 478-484. [Abstract] [Full Text]

Acute Administration of Fish Oil Inhibits Triggered Activity in Isolated Myocytes From Rabbits and Patients With Heart Failure
Hester M. Den Ruijter, Géza Berecki, Arie O. Verkerk, Diane Bakker, Antonius Baartscheer, Cees A. Schumacher, Charly N.W. Belterman, Nicolaas de Jonge, Jan W.T. Fiolet, Ingeborg A. Brouwer, and Ruben Coronel
Circulation 2008 117: 536-544. [Abstract] [Full Text]

Egg Consumption and Risk of Heart Failure in the Physicians’ Health Study
Luc Djoussé and J. Michael Gaziano
Circulation 2008 117: 512-516. [Abstract] [Full Text]

Pulmonary Vein Region Ablation in Experimental Vagal Atrial Fibrillation: Role of Pulmonary Veins Versus Autonomic Ganglia
Kristina Lemola, Denis Chartier, Yung-Hsin Yeh, Marc Dubuc, Raymond Cartier, Andrew Armour, Michael Ting, Masao Sakabe, Akiko Shiroshita-Takeshita, Philippe Comtois, and Stanley Nattel
Circulation 2008 117: 470-477. [Abstract] [Full Text]